Skip to main content
Caplight Logo









Ecovia Bio

Ecovia Bio

Private
Livonia, MichiganEnergy & Sustainabilityhttps://ecovia-bio.com/

Last Round

Series B

Feb 3, 2026

Total Funding Raised

$1.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ecovia Bio is a biotechnology company that develops and commercializes sustainable, high-performance biopolymers derived from fermentation processes for the cosmetics, personal care, and agriculture industries.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials, Advanced Materials, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopolymerbiodegradable polymergamma polyglutamic acidγ-PGAgreen chemistrysustainable materialsbio-based ingredientsindustrial fermentationbiotech manufacturingmicroplastic alternativescosmetic ingredientsclean beautyspecialty chemicalsbio-manufacturingsynthetic polymer replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ecovia Bio Comparables

Compare Ecovia Bio with similar companies based on industry and business-model similarity.

Ecovia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanjing Shineking Biotech Co., Ltd.
86%
Itaconix plc
76%
Lygos
74%

Ecovia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 3, 2026
SeedOct 3, 2018

Key People

Founding team and executive leadership

Kousay Said

Chief Executive Officer

Executive Team

Ecovia Bio Investors

Notable investors and investment history

Ecovia Bio investors
InvestorRounds
Pointe AngelsSeries B
Accelerate Blue FundSeries B
Pointe AngelsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Led by Pointe Angels with participation from Accelerate Blue Fund.

  • Mar 27, 2025

    Monthly visitors grew 40% MoM.

Ecovia Bio Filings

Explore SEC and related filing metadata, where available.

Ecovia Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ecovia Bio's valuation, stock price, and market status.

Is Ecovia Bio a public or private company?

Ecovia Bio is a private company.

What is the current stock price of Ecovia Bio?

Ecovia Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Ecovia Bio worth (valuation)?

Valuation information for Ecovia Bio is not publicly available.

Can I buy Ecovia Bio stock?

Ecovia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ecovia Bio's last funding round?

Ecovia Bio's most recent funding round was Series B on February 3, 2026.

Who are the main investors in Ecovia Bio?

Key investors in Ecovia Bio include Pointe Angels, Pointe Angels.

Will Ecovia Bio IPO soon?

No public IPO plans have been announced for Ecovia Bio.

How can I track Ecovia Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ecovia Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLivonia, Michigan
Employee Range9
Year Founded2014
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?